首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 4期中西医结合肝胆胰疾病 => 专家论坛 =>病毒性肝炎防治新形势下对中医..
病毒性肝炎防治新形势下对中医药防治肝纤维化的思考
Traditional Chinese medicine prevention and treatment of liver fibrosis under the new situation of prevention and treatment of viral hepatitis
文章发布日期:2018年04月04日  来源:  作者:池晓玲, 萧焕明  点击次数:465次  下载次数:103次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:抗肝纤维化是中医药防治病毒性肝炎特色优势的重要体现。《2016-2021年全球卫生部门病毒性肝炎战略》、《中国病毒性肝炎防治规划(2017-2020)》的发布为中医药防治肝纤维化带来机遇。如何提高肝纤维化的疗效、研发更多抗肝纤维化的有效中药新药是新形势下中医药防治肝纤维化研究的挑战。以提高临床疗效为目的,从肝纤维化发生发展的不同阶段着手,发挥中医辨证论治的优势,早期干预,并联合精准医学、中医特色慢病管理等手段开展临床与基础研究,进一步建立并推广应用中医药防治肝纤维化的临床诊疗指南及中医药防治肝纤维化的中医特色慢病管理指南是未来中医药防治肝纤维化研究的重要内容。
【Abstract】:The prevention and treatment of liver fibrosis is an important embodiment of the characteristic advantage of traditional Chinese medicine (TCM) in the prevention and treatment of viral hepatitis. The release of Global Health Sector Strategy on Viral Hepatitis, 2016-2021 and Viral Hepatitis Prevention and Control Plan of China (2017-2020) brings opportunities to TCM prevention and treatment of liver fibrosis. There are still challenges in the research on TCM prevention and treatment of liver fibrosis, including how to improve the outcome of liver fibrosis and the research and development of more effective TCM new drugs for liver fibrosis. With the purpose of improving the clinical effect, we will start from the different stages of the development and progression of liver fibrosis, use the advantages of TCM syndrome differentiation-based treatment, provide early intervention, conduct clinical and basic research with the combination of precision medicine and TCM management of chronic diseases, and further establish and promote the application of the guidelines for clinical diagnosis and treatment of liver fibrosis and the TCM management guidelines for chronic diseases, which are the important contents of TCM prevention and treatment of liver fibrosis in future.
【关键字】:肝硬化; 肝炎, 病毒性, 人; 中医疗法
【Key words】:liver cirrhosis; hepatitis, viral, human; TCM therapy
【引证本文】:CHI XL, XIAO HM. Traditional Chinese medicine prevention and treatment of liver fibrosis under the new situation of prevention and treatment of viral hepatitis[J]. J Clin Hepatol, 2018, 34(4): 694-697. (in Chinese)
池晓玲, 萧焕明. 病毒性肝炎防治新形势下对中医药防治肝纤维化的思考[J]. 临床肝胆病杂志, 2018, 34(4): 694-697.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号